10X Genomics
Pleasanton
CA
94566
United States
145 articles about 10X Genomics
-
10x Genomics Reports First Quarter 2023 Financial Results
5/3/2023
10x Genomics, Inc. reported financial results for the first quarter ended March 31, 2023.
-
10x Genomics to Present at the BofA Securities 2023 Healthcare Conference
4/25/2023
10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced that members of its management team will participate in a fireside chat at the BofA Securities 2023 Healthcare Conference on Wednesday, May 10, at 2:20 p.m. Pacific Time.
-
10x Genomics to Report First Quarter 2023 Financial Results on May 3, 2023
4/12/2023
10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced it will report financial results for the first quarter 2023 after market close on Wednesday, May 3, 2023.
-
10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference
2/22/2023
10x Genomics, Inc. announced the company will be participating in the upcoming 43rd Annual Cowen Healthcare Conference in Boston, Massachusetts.
-
10x Genomics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Outlook for 2023
2/15/2023
10x Genomics, Inc. reported financial results for the fourth quarter and full year ended December 31, 2022 and provided outlook for 2023.
-
Ultima Genomics Announces Collaboration with 10x Genomics to Enable Seamless Integration of Chromium Single Cell Applications on Ultima Sequencers
2/6/2023
Ultima Genomics, Inc. and 10x Genomics today announced a collaboration to integrate use of the 10x Genomics Chromium Single Cell Gene Expression solutions with Ultima's advanced ultra-high throughput sequencing systems.
-
10x Genomics Demonstrates Breadth, Scale and Leadership at 2023 AGBT General Meeting
2/6/2023
10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology, today announced a series of new product updates and technology demonstrations that will be presented at the 2023 Advances in Genome Biology and Technology (AGBT) General Meeting this week in Hollywood, Fla.
-
10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023
1/19/2023
10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after market close on Wednesday, February 15, 2023.
-
10x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
12/28/2022
10x Genomics, Inc., a life sciences leader focused on mastering biology to advance human health, announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California.
-
10x Genomics Commercially Launches Xenium Platform for In Situ Analysis
12/8/2022
10x Genomics, Inc., a life sciences leader focused on mastering biology to advance human health, announced the first commercial shipments of its Xenium platform for in situ analysis.
-
Jumpcode Genomics Joins 10x Genomics' Compatible Partner Program (CPP)
11/30/2022
Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, announced a partnership with 10x Genomics to integrate the Jumpcode Single Cell RNA Boost Kit with the 10x Genomics Chromium Single Cell Gene Expression platform.
-
10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discovery
11/9/2022
10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the commercial availability of BEAM (Barcode Enabled Antigen Mapping), a kitted solution for antibody and T-cell receptor (TCR) discovery.
-
10x Genomics Reports Third Quarter 2022 Financial Results
11/2/2022
10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2022.
-
10x Genomics to Host Investor Day on December 8, 2022
10/31/2022
10x Genomics announced it will host an Investor Day on December 8, 2022 at the company's headquarters in Pleasanton, CA starting at 9:00 a.m. Pacific Time.
-
10x Genomics to Report Third Quarter Financial Results on November 2, 2022
10/12/2022
10x Genomics announced it will report financial results for the third quarter 2022 after market close on Wednesday, November 2, 2022.
-
The gene sequencing industry has really taken off in recent years. Here's a look at the top five genome sequencing companies, ranked by revenue. -
10x Genomics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
9/2/2022
10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference in New York, New York.
-
Biogen expects to lay off a potential 1,000 staffers in an effort to cut about $1 billion in costs, according to The Boston Globe, while 10x Genomics and Talis Biomedical also cut staff. -
10x Genomics Reports Second Quarter 2022 Financial Results
8/8/2022
10x Genomics, Inc. reported financial results for the second quarter ended June 30, 2022.
-
10x Genomics Names Jim Wilbur as Chief Commercial Officer
7/14/2022
Following a comprehensive search process, 10x Genomics, Inc., announced the hiring of Jim Wilbur, Ph.D., as Chief Commercial Officer, effective July 27.